Eric D Ferguson

US Patent:

7546262, Jun 9, 2009

Filed:

Mar 24, 2005

Appl. No.:

10/907194

Inventors:

Eric J. Ferguson - Phoenix AZ, US
Ralph Concetto Rizza - Charlotte NC, US

Assignee:

Bank of America Corporation - Charlotte NC

International Classification:

G06Q 40/00

US Classification:

705 35

Abstract:

System and method for managing debt collection using clustering. Debt collection treatment for a delinquent account can be determined in a reliable and consistent way by examining historical credit and demographic data for the debtor. In some embodiments, a plurality of behavior clusters within a multi-dimensional space for modeling debtor behavior are established using representative portfolio data. Result probabilities for various stimuli to be applied to the customer can be represented by a difference score, which indicates a difference in result flowing from the presence of particular stimuli versus the absence of the stimuli. The difference scores for the various stimuli, when normalized, can be used to assign the delinquent account to a cluster, which determines the treatment to be applied to the account.

US Patent:

20080065395, Mar 13, 2008

Filed:

Aug 25, 2006

Appl. No.:

11/510089

Inventors:

Eric J. Ferguson - Phoenix AZ, US

International Classification:

G06Q 10/00

US Classification:

705 1

Abstract:

An intelligent marketing system receives a customer list from a client and acquires a list of prospects for the client. One or more demographic attributes is appended to the list. A logistic regression is performed to calculate the probability of response from each prospect. The client selects one or more prospects to contact based on a scaled score. The system creates a contact file with the selected prospects and includes a unique response code for each desired prospect. The contact file is sent to a distribution center and each selected prospect is contacted. The unique response code is included with each contact. One or more prospects responds and is recognized due to the unique response code. The prospective customer selects a particular offer which is recorded in the contact file. The client accesses the web site and each prospective customer individually. Contacts and responses are correlated for each prospect.

US Patent:

20200354778, Nov 12, 2020

Filed:

Jul 28, 2020

Appl. No.:

16/941333

Inventors:

- Madison WI, US
- Bethesda MD, US
Sarah K. Abey - Bethesda MD, US
Nicolaas H. Fourie - Bethesda MD, US
Eric G. Ferguson - Bethesda MD, US

Assignee:

GODX, INC - Madison WI
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES - Bethesda MD

International Classification:

C12Q 1/6834
C12Q 1/70
G01N 15/06
C12Q 1/00
G01N 15/10
G01N 15/14
C12Q 1/689
C12Q 1/6816
G01N 33/487
B01L 3/00
C12Q 1/6825
C12Q 1/6888

Abstract:

The present invention relates to the rapid and electricity-free, point-of-care, multiplexed detection and quantification of at least one or more nucleic acid sequences from nucleic acids corresponding to a plurality of pathogens or biomarkers using a micropatterned lateral flow device. Rapid and molecular-level sensitive differential diagnosis of a disease condition may be enabled without the need for a delayed laboratory test so that timely treatment can be administered.

US Patent:

20180148774, May 31, 2018

Filed:

May 16, 2016

Appl. No.:

15/574750

Inventors:

- Madison WI, US
- Bethesda MD, US
Sarah K. Abey - Bethesda MD, US
Nicolaas H. Fourie - Bethesda MD, US
Eric G. Ferguson - Bethesda MD, US

Assignee:

GODX, INC - Madison WI
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVIC - Bethesda MD

International Classification:

C12Q 1/6834
B01L 3/00
C12Q 1/70
C12Q 1/6888
C12Q 1/6825

Abstract:

The present invention relates to the rapid and electricity-free, point-of-care, multiplexed detection and quantification of at least one or more nucleic acid sequences from nucleic acids corresponding to a plurality of pathogens or biomarkers using a micropatterned lateral flow device. Rapid and molecular-level sensitive differential diagnosis of a disease condition may be enabled without the need for a delayed laboratory test so that timely treatment can be administered.